Objective
The project proposed by the fellow Evelyn Jantscher-Krenn and the scientist in charge, Gernot Desoye, Medical University of Graz, Austria, aims at pinpointing the potential role of Human Milk Oligosaccharides (HMO) as biomarkers in metabolic diseases in pregnancy. HMO are immunomodulatory glycans in breast milk that are also present in the systemic circulation of pregnant women. New evidence detecting HMO in the umbilical cord blood (fetal circulation), raises the question whether prenatal HMO can influence pregnancy outcomes and developmental programming of the fetus. In breast milk, HMO concentration and composition are dependent on genetic, but potentially also environmental factors. We therefore hypothesize that prenatal HMO have an impact on the health of mother and fetus, and are correlated with life-style induced metabolic changes. To test the hypothesis, three project objectives are formulated: Objective 1 longitudinally determines maternal HMO concentration and composition in serum to describe variability and temporal changes during pregnancy. Objective 2 determines fetal HMO concentration and composition in arterial and venous cord blood, in comparison to maternal HMO, to gain insight about origin. Objective 3 investigates associations of prenatal HMO (maternal/fetal) with both, maternal factors (maternal body mass index and physical activity) and fetal outcomes (fetal growth and body composition). Biological specimens for HMO analysis and data for objective 3 will be available through an existing cohort study. For the implementation of this IIF, the fellow will transfer HMO analysis methods from the University of California, San Diego, USA, and combine this knowledge and technology with expertise in Perinatology at the Medical University of Graz. As such, the project will contribute to establishing the emerging field of HMO research in Europe and form the basis for the fellow’s career vision of pioneering the field of HMO in Perinatology.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- medical and health sciences clinical medicine obstetrics fetal medicine
- natural sciences biological sciences biochemistry biomolecules carbohydrates
- medical and health sciences clinical medicine embryology
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP7-PEOPLE-2013-IIF
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
8010 GRAZ
Austria
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.